References
- American Chronic Pain Association. ACPA Resource Guide. 2016. Available from: www.theacpa.org
- Simon LS. Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Journal of Pain & Palliative Care Pharmacotherapy. 2012;26(2):197–198.
- Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454(7203):428–435.
- Tal M. A role for inflammation in chronic pain. Curr Rev Pain. 1999;3(6):440–446.
- Marchand F, Perretti M, McMahon SB. Role of the immune system in chronic pain. Nat Rev Neurosci. 2005;6(7):521–532.
- Watkins LR, Maier SF, Goehler LE. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain. 1995;63(3):289–302.
- Clark AK, Old EA, Malcangio M. Neuropathic pain and cytokines: current perspectives. J Pain Res. 2013;6:803–814.
- Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011;152(3Suppl):S2–S15.
- Tennant F. Hormone abnormalities in patients with severe and chronic pain who fail standard treatments. Postgrad Med. 2015;127:1–4.
- Tennant FS, Robinson D, Sagherian A, et al. Chronic opioid treatment of intractable non-malignant pain. NIDA Res Monogr. 1988;81:174–180.
- Tennant F. The physiologic effects of pain on the endocrine system. Pain Ther. 2013;2(2):75–86.
- Dolan RA. Spinal adhesive arachnoiditis. Surg Neurol. 1993;39(6):479–484.
- Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Internal Med. 2001;16:606–613.
- Gettins PG. Serpin structure, mechanism, and function. Chem Rev. 2002;102(12):4751–4804.
- Arnhold J. Properties, functions, and secretion of human myeloperoxidase. Biochemistry. 2004;69(1):4–9.
- van der Veen BS, de winther MP, Heeringa P. Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease. Antioxid Redox Signal. 2009;11(11):2899–2937.
- Van Zee KJ, Kohno T, Fischer E, et al. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci. 1992;89(11):4845–4849.
- Tennant F, Hermann L. Using biologic markers to identify legitimate chronic pain. Am Clin Lab. 2002;21(5):14.
- Tennant F. Erythrocyte sedimentation rate and C-reactive protein: old but useful biomarkers for pain treatment. Pract Pain Manage. 2013 [cited 2013 Mar 1]. Available from: http://www.practicalpainmanagement.com
- Lefkowitz DL, Lefkowitz SS. Microglia and myeloperoxidase: a deadly partnership in neurodegenerative disease. Free Radic Biol Med. 2008;45(5):726–731.
- Dublin P, Hanani M. Satellite glial cells in sensory ganglia: their possible contribution to inflammatory pain. Brain Behav Immun. 2007;21(5):592–598.
- Gray E, Thomas TL, Betmouni S, et al. Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis. Brain Pathol. 2008;18(1):86–95.
- Choi DK, Pennathur S, Perier C, et al. Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson’s disease in mice. J Neurosci. 2005;25(28):6594–6600.
- Ellis A, Bennett DL. Neuroinflammation and the generation of neuropathic pain. Br J Anaesth. 2013;111(1):26–37.
- Chang L, Munsaka SM, Kraft-Terry S, et al. Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain. J Neuroimmune Pharmacol. 2013;8(3):576–593.